Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain

OBJECTIVE: To explore adherence/persistence with generic gabapentin/venlafaxine versus brand-name gabapentin/venlafaxine (Neurontin(®)/Vandral(®)) in peripheral neuropathic pain (pNP) or generalized anxiety disorder (GAD), respectively, and whether it is translated into different costs and patient o...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicras-Mainar, Antoni, Rejas-Gutiérrez, Javier, Navarro-Artieda, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461091/
https://www.ncbi.nlm.nih.gov/pubmed/26082655
http://dx.doi.org/10.2147/CEOR.S85756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461091/
https://www.ncbi.nlm.nih.gov/pubmed/26082655
http://dx.doi.org/10.2147/CEOR.S85756

Ejemplares similares